RANDI BRAGG: Open Payments
NPI 1700420031 · MARION, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 66 payments from 15 companies in 2025. Trend: 2023 $941 · 2024 $805 · 2025 $1,339
Food & beverage: $1,255Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $238 |
| Corcept Therapeutics | 5 | $184 |
| Vanda Pharmaceuticals Inc. | 12 | $157 |
| PFIZER INC. | 9 | $155 |
| Axsome Therapeutics, Inc. | 7 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $136 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Biogen, Inc. | 2 | $50 |
| Gilead Sciences, Inc. | 1 | $21 |
Products named: Korlym, Auvelity, FANAPT, Kerendia, VRAYLAR, REXULTI, QULIPTA, ZAVZPRET.
Industry payments across IN — which companies pay providers there.
